UBS Initiates Coverage on SOFTCARE (02698) with "Buy" Rating, Targets HK$41

Stock News2025-12-23

UBS issued a research report initiating coverage on SOFTCARE (02698) with a "Buy" rating and a target price of HK$41. The company is uniquely positioned to capture long-term structural growth in Africa's hygiene products consumption, benefiting from favorable demographics, low category penetration, and decades-long economic and consumer growth runway. As a regional leader, SOFTCARE maintains a durable moat through scale, localized manufacturing, distribution, and execution capabilities.

The bank believes SOFTCARE can sustain a 15% compound annual growth rate (CAGR) in sales from 2026 to 2028 while maintaining resilient margin structures. With potential tailwinds from forex dynamics and additional optionality from Latin American expansion, UBS views the stock's 18x P/E ratio—aligned with a 15% EPS CAGR (2026-2028)—as an attractive risk-reward proposition with long-term earnings growth potential.

UBS also forecasts stable margin structures for SOFTCARE from 2026 to 2028, supported by cost efficiencies driven by localized manufacturing and economies of scale. Potential forex tailwinds could further bolster average selling prices (ASP). Additionally, stable raw material price outlooks may reduce input cost volatility.

Looking ahead, the bank sees upside margin potential from Latin American penetration, where retail ASPs exceed those in Africa. Geographic diversification could drive structurally higher profitability over time.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment